4 high-quality ASX 200 growth shares to buy in June

Analysts think these stocks could supercharge your portfolio.

| More on:
A smiling businessman in the city looks at his phone and punches the air in celebration of good news.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are you wanting to add some ASX 200 growth shares to your portfolio this month?

If you are, then it could be well worth checking out the four buy-rated options listed below. Here's what you need to know about these high-quality stocks:

NextDC Ltd (ASX: NXT)

Goldman Sachs thinks that NextDC is an ASX 200 growth share to buy. It is one of the region's leading colocation service providers from its growing collection of world-class data centres.

It likes the company due to "the rapid growth in cloud adoption, which has been supported by the continued evolution of the enterprise telecommunications market, and the significant demand by both public and private investors for digital infrastructure assets."

Goldman currently has a buy rating and an $18.59 price target on its shares.

ResMed Inc. (ASX: RMD)

Another ASX 200 growth share that could be a buy in June is ResMed. It is a sleep treatment-focused medical device company with an industry-leading portfolio of hardware and software solutions.

It has been tipped to grow strongly over the long term. This is thanks largely to the quality of its products and huge market opportunity. In respect to the latter, management estimates that there are 1 billion people impacted by sleep apnoea worldwide. However, only ~20% of these sufferers are believed to have been diagnosed.

Macquarie is bullish on ResMed and has an outperform rating and a $34.85 price target on its shares.

Treasury Wine Estates Ltd (ASX: TWE)

A third ASX 200 growth share that could be a buy is Treasury Wine. It is one of the world's largest wine companies and the owner of a collection of very popular brands. The jewel in the crown is of course Penfolds.

Morgans rates the wine giant highly and believes its recent US acquisition could prove to be a great addition. It notes that the addition of DAOU Vineyards "is in line with TWE's premiumisation and growth strategy and will strengthen a key gap in Treasury Americas (TA) portfolio."

The broker currently has an add rating and a $14.03 price target on its shares.

Xero Limited (ASX: XRO)

A final ASX 200 growth share that could be a buy in June is Xero. It is a cloud accounting platform provider with ~4.16 million subscribers globally.

But if you thought this number was close to peaking, think again. Management estimates that its addressable market is 45 million subscribers, which means it has only captured a small slice of its market so far.

Goldman Sachs thinks its market opportunity could be even larger. Its analysts "see Xero as very well-placed to take advantage of the digitisation of SMBs globally, driven by compelling efficiency benefits and regulatory tailwinds, with >100mn SMBs worldwide representing a >NZ$100bn TAM."

The broker has a buy rating and a $164.00 price target on Xero's shares.

Motley Fool contributor James Mickleboro has positions in Nextdc, ResMed, Treasury Wine Estates, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, Macquarie Group, ResMed, and Xero. The Motley Fool Australia has positions in and has recommended Macquarie Group, ResMed, and Xero. The Motley Fool Australia has recommended Treasury Wine Estates. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Growth Shares

3 monster stocks to hold for the next 3 years

These 3 ASX shares operate in different industries and could be worth holding for long-term growth over the next 3…

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Growth Shares

2 ASX growth shares to snap up while they're still down

Brokers see plenty of upside for these mainstay sector picks.

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Growth Shares

Why these ASX growth stocks could be much bigger in 2030 than today

These stocks have long growth runways and strong business models.

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Growth Shares

3 incredible ASX growth shares to buy and hold forever in 2026

True long-term investing means owning businesses you’d be happy to hold through volatility, uncertainty, and decades of change.

Read more »

Happy work colleagues give each other a fist pump.
Growth Shares

2 shares to buy hand over fist before the ASX 200 soars higher in 2026

These shares are highly rated by brokers for a reason. Here's what you need to know about them.

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Broker Notes

Experts rate these 2 ASX shares as buys this month!

Leading analysts say these stocks are a buy.

Read more »

Happy healthcare workers in a labs
Technology Shares

Prediction: CSL shares could soar past $270 in 2026

Here's what to expect from the Australian-based global biotechnology company this year.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Growth Shares

2 unstoppable ASX 200 stocks to buy in 2026 and hold forever

These blue chips could have very bright futures. Do you own them?

Read more »